On December 18, 2023, the U.S. Food and Drug Administration (FDA) issued two announcements regarding the law of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), specifically concerning the requirements for cosmetic facility registration and cosmetic product listing. First of all, the FDA launched the "Cosmetics Direct" electronic submission portal to accept information about product listings and cosmetic facility registrations. Second, the FDA published its final guidelines regarding the information that must be submitted with listings and registrations.
The Agency is not enforcing facility registration or product listing requirements until July 1, 2024, as noted in a compliance policy announced on November 8, 2023. However, companies should start following the new regulations. More details are discussed below.
According to the FDA's announcement, companies can now submit facility registration, product listing, and labeling information to the FDA by using the Cosmetics Direct electronic portal. Cosmetics Direct is accessed at https://direct.fda.gov/.
As the FDA described the portal is a "Structured Product Labeling (SPL) authoring tool, for cosmetic product facility registration and cosmetic product listing. It includes user-friendly data entry forms, creates and saves the SPL submission, performs initial validations, and submits the SPL to FDA for internal processing." Information about cosmetic labeling must be sent in SPL format. There's also a detailed user's guide for Cosmetics Direct available. In general, creating an account is required for every party wanting to submit information through the portal.
The portal is now available for businesses that submit this information electronically, even though the FDA declared that it would not enforce the facility registration and product listing requirements for an extra six months after the December 29, 2023, statutory deadline (until July 1, 2024). Significantly, the other MoCRA requirements that go into effect on December 29, 2023, such as the requirement to report serious adverse events and to keep records confirming the safety of cosmetics, are not impacted by this enforcement delay.
The FDA also issued final guidance with suggestions and instructions to help stakeholders with cosmetic product facility registration and product listing submissions to the FDA. The guidance provides information about
1) who is responsible for making registration and listing submissions
2) what information to include
3) how to submit
4) when to submit
5) certain exemptions to the registration and listing requirements
When registering for the first time, a cosmetic company must include its facility registration number. The facility registration number assigned by the Agency will be the FDA Establishment Identifier (FEI) number.
Appendix B of the Final Guidance has a section titled "Frequently Asked Questions" (FAQs). This part is being released "for comment purposes only," meaning it is effectively a draft version. However, it's important to read these FAQs since they provide more insight into how the FDA is interpreting specific parts of the registration and listing standards.
If you have questions about the registration or listing requirements, or any other provisions of MoCRA, or want to apply for FEI numbers please feel free to contact us.
Related Service